| MeSH term | MeSH ID | Detail |
|---|---|---|
| Heart Failure | D006333 | 36 associated lipids |
| Arthritis, Rheumatoid | D001172 | 3 associated lipids |
| Osteitis | D010000 | 10 associated lipids |
| Coronary Disease | D003327 | 70 associated lipids |
| Prostatic Neoplasms | D011471 | 126 associated lipids |
| Osteosarcoma | D012516 | 50 associated lipids |
| Hip Fractures | D006620 | 2 associated lipids |
| Osteolysis | D010014 | 8 associated lipids |
| Hypothyroidism | D007037 | 32 associated lipids |
| Osteoarthritis, Hip | D015207 | 4 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| pmid:28041995 | ||||
| pmid:28044198 | ||||
| Hygum K et al. | MECHANISMS IN ENDOCRINOLOGY: Diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis. | 2017 | Eur. J. Endocrinol. | pmid:28049653 |
| Sponder M et al. | Endurance training significantly increases serum endocan but not osteoprotegerin levels: a prospective observational study. | 2017 | BMC Cardiovasc Disord | pmid:28056805 |
| Chen H et al. | [Effects of laser solid forming of porous titanium on proliferation of osteoblast and RANKL/OPG expression]. | 2016 | Zhong Nan Da Xue Xue Bao Yi Xue Ban | pmid:28070039 |
| Ji J et al. | Pathway of 3-MCPD-induced apoptosis in human embryonic kidney cells. | 2017 | J Toxicol Sci | pmid:28070108 |
| Toffoli B et al. | Dyslipidemia and Diabetes Increase the OPG/TRAIL Ratio in the Cardiovascular System. | 2016 | Mediators Inflamm. | pmid:28070143 |
| pmid:28077433 | ||||
| pmid:28079506 | ||||
| Shu R et al. | Sclerostin Promotes Bone Remodeling in the Process of Tooth Movement. | 2017 | PLoS ONE | pmid:28081119 |
| pmid:28088671 | ||||
| Bergamini A et al. | Expression of the receptor activator of nuclear factor-kB ligand in peripheral blood mononuclear cells in patients with acute Charcot neuroarthropathy. | 2016 | Int J Med Sci | pmid:28090190 |
| pmid:28091892 | ||||
| Liu XY et al. | Protective effects of total flavonoids of Astragalus against adjuvant-induced arthritis in rats by regulating OPG/RANKL/NF-κB pathway. | 2017 | Int. Immunopharmacol. | pmid:28092862 |
| Bondar C et al. | Osteocyte Alterations Induce Osteoclastogenesis in an In Vitro Model of Gaucher Disease. | 2017 | Int J Mol Sci | pmid:28098793 |
| pmid:28115012 | ||||
| Yin LL et al. | Relationship between the gene polymorphism of osteoprotegerin and bone mineral density in hemodialysis patients. | 2017 | Eur Rev Med Pharmacol Sci | pmid:28121359 |
| pmid:28126632 | ||||
| pmid:28127738 | ||||
| pmid:28130552 | ||||
| Chung ST et al. | Osteoprotegerin mediates tumor-promoting effects of Interleukin-1beta in breast cancer cells. | 2017 | Mol. Cancer | pmid:28143606 |
| pmid:28153008 | ||||
| pmid:28161839 | ||||
| Kuroyanagi G et al. | (-)-Epigallocatechin gallate synergistically potentiates prostaglandin E2-stimulated osteoprotegerin synthesis in osteoblasts. | 2017 | Prostaglandins Other Lipid Mediat. | pmid:28163121 |
| pmid:28165889 | ||||
| Fortner RT et al. | Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort. | 2017 | BMC Med | pmid:28173834 |
| pmid:28189120 | ||||
| Xiong L et al. | Osteoblastic Lrp4 promotes osteoclastogenesis by regulating ATP release and adenosine-A2AR signaling. | 2017 | J. Cell Biol. | pmid:28193701 |
| pmid:28214531 | ||||
| Fioramonti M et al. | Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions. | 2017 | Oncotarget | pmid:28223547 |
| Hanmoto T et al. | Effects of low-intensity pulsed ultrasound on osteoclasts: Analysis with goldfish scales as a model of bone. | 2017 | Biomed. Res. | pmid:28239034 |
| pmid:28244247 | ||||
| pmid:28244588 | ||||
| Irtyuga O et al. | NOTCH1 Mutations in Aortic Stenosis: Association with Osteoprotegerin/RANK/RANKL. | 2017 | Biomed Res Int | pmid:28246602 |
| Lu LY et al. | Pro-inflammatory M1 macrophages promote Osteogenesis by mesenchymal stem cells via the COX-2-prostaglandin E2 pathway. | 2017 | J. Orthop. Res. | pmid:28248001 |
| pmid:28249772 | ||||
| pmid:28252575 | ||||
| Shetelig C et al. | Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular function. | 2017 | PLoS ONE | pmid:28253327 |
| pmid:28253591 | ||||
| pmid:28257738 | ||||
| pmid:28259984 | ||||
| Jia J et al. | Estrogen stimulates osteoprotegerin expression via the suppression of miR-145 expression in MG-63 cells. | 2017 | Mol Med Rep | pmid:28260003 |
| pmid:28260080 | ||||
| Songia P et al. | Identification of Patients Affected by Mitral Valve Prolapse with Severe Regurgitation: A Multivariable Regression Model. | 2017 | Oxid Med Cell Longev | pmid:28261377 |
| pmid:28263839 | ||||
| pmid:28285639 | ||||
| pmid:28290259 | ||||
| pmid:28302565 | ||||
| pmid:28303296 | ||||
| pmid:28318623 |